Reuters -- Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation (NOVN.VX) have agreed to pay $72.5 million to settle false claims allegations about the marketing of its cystic fibrosis drug TOBI, the U.S. Justice Department said on Tuesday.
